top of page

Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.

Our Research Themes

Personalised Treatments in MS

We are using big data and cutting-edge artificial intelligence to identify the right drug, for the right person at the right time.

Clinical Trials & Remyelination

We are conducting groundbreaking research in the field of remyelination, dedicated to repairing the nervous system.

Ageing &
Brain Health

We are elucidating the relationship between biological ageing, neurological repair and neuronal loss to identify novel treatment pathways.

Latest News

Adam Turna Presents CCMR Two Outcomes at MS Frontiers 2026

​​18th June 2026
 

It was great to have Adam Turna present the eye-tracking outcomes from our CCMR Two trial at the recent MS Frontiers Conference, highlighting an important component of the study.yy'sy findings.​​

CCMSR Website - Adam Turna at MS Frontiers 2026.jpg

Public Collaborators

People living with multiple sclerosis are partners in our research: helping shape the questions, the science and the impact.

​

​

We recognise that we cannot truly understand the needs of people living with MS in our community unless our Public Collaborators Council has representatives from diverse backgrounds and life experiences, including often overlooked groups.

Valued Supporters

MS Society UK Logo
The Evelyn Trust Logo
Ferblanc Logo
Wellcome Trust Logo
The Academy of Medical Sciences Logo
British Medical Association Logo
Jon Moulton Charity Trust Logo
UK Medical Research Council Logo

Key Collaborators

Cambridge Centre for Myelin Repair Logo
University College London Logo
Macquarie University Hospital Logo
University of Auckland Logo
Amsterdam UMC Logo
University of Sydney Logo

© 2026 by Cambridge Clinical MS Research. All rights reserved.

bottom of page